Eyepoint

Shaping the Future of Retinal Care

Overview

As a long-standing leader in the eye care space, EyePoint was undergoing a strategic shift, from its pharmaceutical roots to a more biotech-forward future. With deep expertise in drug delivery and a growing pipeline of therapies that simplify and enhance treatment for retinal diseases like wet AMD, they were ready for a reimagination of their brand.

This repositioning marked a unique departure from our typical biotech brand projects. Rather than creating a new identity from the ground up, ICS partnered with EyePoint to thoughtfully evolve an established brand to reflect the cutting-edge innovation already fueling its work.

Our Role

Brand strategy
Brand identity
UX/UI Design
WordPress development
Collateral
Brand Guidelines

Industry

Biotech & Life Science

The creative solution

This new digital presence highlights innovation, expands the visual identity, and better communicates EyePoint’s scientific leadership. As part of the engagement, ICS also designed EyePoint’s Investor Relations (IR) site, an essential and critical platform for this public company. In fact, one of the most pressing needs we identified during discovery was to ensure a seamless transition between the corporate and IR sites. This was critical not only for UX, but in reinforcing brand consistency, and building trust with investors and stakeholders alike.

Throughout the new site, we emphasized the concept of vision both literally and metaphorically by incorporating imagery of the eye to evoke clarity and focus. We modernized the visual identity by expanding the original color palette and introduced updated scientific imagery to better showcase EyePoint’s depth of expertise while staying within the newly established design system.

A cohesive brand

The result is a refreshed digital presence that feels both forward-looking and deeply-rooted in the company’s commitment to innovation in retinal care.